Posts tagged Cong
Rescission Watch: Take action to protect cancer research funding!

We joined with other research advocates to thank Congressional appropriations leaders for securing an unprecedented $3 billion increase in NIH funding as part of the FY2018 omnibus spending bill. This boost to medical research funding comes at a critical time, as advances in precision medicine hold the key to more children surviving and thriving after a cancer diagnosis than ever before.

But then, we started hearing a term called 'rescission' thrown around in Washington. An appropriations process that we had celebrated as a victory for medical research suddenly started to sound not-so-final. 

Read More